Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 20Active not recruiting 12Not yet recruiting 6Completed 6Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1CNS 1

Conditions

Rhabdomyosarcoma 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Hematologic Neoplasms 1Desmoplastic Small Round Cell Tumor 1

Interventions

pembrolizumab 117Nivolumab 48Carboplatin 48Paclitaxel 35Cyclophosphamide 35Cisplatin 34Gemcitabine 30atezolizumab 27Specimen Handling 25Magnetic Resonance Spectroscopy 25venetoclax 24Pemetrexed 24Docetaxel 24fludarabine 23Ipilimumab 23Biopsy 22Bevacizumab 22Radiotherapy 21Azacitidine 20Fluorouracil 19Dexamethasone 19Radiosurgery 18durvalumab 17Leucovorin 16Trastuzumab 15Cetuximab 15Capecitabine 15fludarabine phosphate 14Cytarabine 14tislelizumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Thiotepa × 1 year × Clear all
NCT05579769 2025-10-02

Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.

St. Jude Children's Research Hospital

Phase 2 Terminated
3 enrolled 10 charts
Other hematologic neoplasm

Hematologic Neoplasms

NCT04530487 2025-06-29

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

M.D. Anderson Cancer Center

Phase 2 Terminated
1 enrolled 7 charts
CNSSarcoma

Neuroblastoma, Rhabdomyosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Neurofibrosarcoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡